Literature DB >> 8621261

Establishment and characterization of primary and metastatic uveal melanoma cell lines.

G P Luyten1, N C Naus, C M Mooy, A Hagemeijer, J Kan-Mitchell, E Van Drunen, V Vuzevski, P T De Jong, T M Luider.   

Abstract

We report on the establishment and characterization of 2 primary (EOM-3, EOM-29) and 3 metastatic uveal melanoma cell lines (OMM-1, OMM-2, OMM-3) and further cytogenetic characterization of a previously described primary uveal melanoma cell line (OCM-1). Only a few long-term growing primary uveal melanoma cell lines have as yet been established, while of metastatic uveal melanoma cell lines we have found no descriptions. The morphology of the in vitro cultured cells varied from spindle to epithelioid. The cell lines were characterized by immunocytochemistry, electron microscopy and cytogenetical analysis. The relative growth rate was determined by bromodeoxyuridine (BUdR) incorporation. The melanocytic origin of the cell lines was determined by positive staining with antibodies identifying melanoma-associated antigens. Melanosomes and pre-melanosomes were indeed observed by electron microscopy in all cell lines. The stem-cell karyotype was found to be normal in 3 cell lines (EOM-29, OMM-2, OMM-3) and abnormal in 3 others (EOM-3, OCM-1, OMM-1) showing a net loss of chromosome 6. The OCM-1 and the OMM-1 cell lines even demonstrated a large amount of structural chromosomal aberrations, the former being near-tetraploid and the latter triploid. The EOM-29 cell line, cultured from a ciliary body melanoma, did not show the previously described chromosome 3 and 8 abnormalities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621261     DOI: 10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

1.  Cell trivision of hyperploid cells.

Authors:  Gabor Nagy; Gabor Kiraly; Melinda Turani; Gaspar Banfalvi
Journal:  DNA Cell Biol       Date:  2013-10-05       Impact factor: 3.311

2.  Verteporfin induces apoptosis and eliminates cancer stem-like cells in uveal melanoma in the absence of light activation.

Authors:  Ya-Wen Ma; Yi-Zhi Liu; Jing-Xuan Pan
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

3.  Characterisation of novel uveal melanoma cell lines under serum-free conditions.

Authors:  D Suesskind; S Gauss; U E A Faust; P Bauer; M Schrader; K U Bartz-Schmidt; S Henke-Fahle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-03       Impact factor: 3.117

4.  Novel amelanotic and melanotic cell lines NM78-AM and NM78-MM derived from a human oral malignant melanoma.

Authors:  Taka Nakahara; Yuichi Tamaki; Noriko Tominaga; Yoshiaki Ide; Masanori Nasu; Akihiro Ohyama; Soh Sato; Isamu Ishiwata; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2010-02-01       Impact factor: 4.174

5.  Tight junction-associated signaling pathways modulate cell proliferation in uveal melanoma.

Authors:  Ashwath Jayagopal; Jin-Long Yang; Frederick R Haselton; Min S Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-01       Impact factor: 4.799

Review 6.  Culturing Uveal Melanoma Cells.

Authors:  Martina Angi; Mieke Versluis; Helen Kalirai
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

7.  Episodic Src activation in uveal melanoma revealed by kinase activity profiling.

Authors:  W Maat; M el Filali; A Dirks-Mulder; G P M Luyten; N A Gruis; L Desjardins; P Boender; M J Jager; P A van der Velden
Journal:  Br J Cancer       Date:  2009-06-30       Impact factor: 7.640

8.  Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Authors:  Nabil Amirouchene-Angelozzi; Fariba Nemati; David Gentien; André Nicolas; Amaury Dumont; Guillaume Carita; Jacques Camonis; Laurence Desjardins; Nathalie Cassoux; Sophie Piperno-Neumann; Pascale Mariani; Xavier Sastre; Didier Decaudin; Sergio Roman-Roman
Journal:  Mol Oncol       Date:  2014-06-13       Impact factor: 6.603

9.  A role for Jag2 in promoting uveal melanoma dissemination and growth.

Authors:  Laura Asnaghi; James T Handa; Shannath L Merbs; J William Harbour; Charles G Eberhart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-09       Impact factor: 4.799

10.  Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.

Authors:  Mariam Kouch-el Filali; Emine Kilic; Marleen Melis; Annelies de Klein; Marion de Jong; Gregorius P M Luyten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.